Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 284 participants.
Also called NCT01841762
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 284 participants
- Sponsor
- Registry
-
NCT01841762
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01841762. Allocation not applicable; no masking; primary purpose treatment. Start 2013-04-01 (actual); primary completion 2015-11-01 (actual). Results posted on 2018-10-31.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Drug)
- Macitentan
- Lead sponsor
- Actelion
Record details
- Record id
cardio:ct-nct01841762- Content hash
cb6b285160581c40054084ef1423bab8cc64675a18cf0874863abe7f45147c3b